Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleCost-utility of Sunitinib Versus Pazopanib in Metastatic Renal Cell Carcinoma in Canada using Real-world Evidence.AuthorsNazha, Sara; Tanguay, Simon; Kapoor, Anil; Jewett, Michael; Kollmannsberger, Christian; Wood, Lori; Bjarnason, G. A. Georg; Heng, Daniel; Soulières, Denis; Reaume, Martin Neil; Basappa, Naveen; Lévesque, Eric; Dragomir, AlicePublicationClinical Drug Investigation, 2018, Vol 38, Issue 12, p1155ISSN1173-2563Publication typeArticleDOI10.1007/s40261-018-0705-6